Orchid Pharma Limited ORCHPHARMA

Latest filings

• Routine15 28 Sept, 18:29 · BSE
  Intimation of Trading Window closure for Quarter-II of Financial Year 2026-27, ending on September 30, 2026.
• M&A73 23 Sept, 20:01 · NSE
  'Trading Approval of Equity Shares issued and allotted under Scheme of Amalgamation'.
• General25 22 Sept, 21:22 · NSE
  'Intimation under Regulation 30 of SEBI ( Listing obligation and Disclosure Requirement) Regulations, 2015'.
• General25 21 Sept, 18:11 · NSE
  'Investor Roadshow Scheduled to be held in Mumbai'.
• Routine15 8 Sept, 20:35 · BSE
  Annual Report of the Company for FY 2025-26.
• Routine15 8 Sept, 16:02 · BSE
  Business Responsibility and Sustainability Report for FY 2025-26
• Routine15 8 Sept, 24:37 · NSE
  'Business Responsibility and Sustainability Report for FY 2025-26'.
• Routine15 7 Sept, 23:53 · NSE
  Shareholders meeting
• Management change38 3 Sept, 20:30 · NSE
  Appointment of cost auditor and change in designation of a Director.
• Board meeting50 3 Sept, 20:11 · NSE
  Outcome of Board Meeting held on September 03, 2026.

Shown 15 minutes after publication. Real time with Pro.